UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Annals of oncology, 2012-06, Vol.23 (6), p.1607-1616

2012

Volltextzugriff (PDF)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

British journal of cancer, 2001-06, Vol.84 (12), p.1577-1585

2001

Volltextzugriff (PDF)

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

Annals of oncology, 2006-04, Vol.17 (4), p.588-596

2006

Volltextzugriff (PDF)

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

Annals of oncology, 2003-09, Vol.14 (9), p.1391-1398

2003

Volltextzugriff (PDF)

Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study

European journal of surgical oncology, 2009-12, Vol.35 (12), p.1326-1332

2009

Volltextzugriff (PDF)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα : predictive role in dose intensive adjuvant chemotherapy

British journal of cancer, 2006-11, Vol.95 (10), p.1334-1341

2006

Volltextzugriff (PDF)

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

European journal of cancer (1990), 2003-03, Vol.39 (5), p.614-621

2003

Volltextzugriff (PDF)

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study

European journal of cancer (1990), 2005, Vol.41 (2), p.225-230

2005

Volltextzugriff (PDF)

Response Shift in Quality of Life Measurement in Early-Stage Breast Cancer Patients Undergoing Radiotherapy

Quality of life research, 2000-01, Vol.9 (6), p.603-615

2000

Volltextzugriff (PDF)

The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, ‘Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients’

Annals of oncology, 2004-02, Vol.15 (2), p.211-217

2004

Volltextzugriff (PDF)

Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer

Journal of clinical oncology, 1997-09, Vol.15 (9), p.3149-3155

1997

Volltextzugriff (PDF)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer : is treatment worthwhile?

British journal of cancer, 2001-06, Vol.84 (12), p.1577-1585

2001

Volltextzugriff (PDF)

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

Bone marrow transplantation (Basingstoke), 2008-10, Vol.42 (7), p.475-481

2008

Volltextzugriff (PDF)

Survival of patients with ovarian cancer due to a mismatch repair defect

Familial cancer, 2005-01, Vol.4 (4), p.301-305

2005

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

The New England journal of medicine, 2010-09, Vol.363 (10), p.943-953

2010

Volltextzugriff (PDF)

Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study

Gynecologic oncology, 2001-06, Vol.81 (3), p.348-354

2001

Volltextzugriff (PDF)

Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas

European journal of cancer (1990), 2004-05, Vol.40 (7), p.963-970

2004

Volltextzugriff (PDF)

Own power: Motives of having electricity without the energy company

Energy policy, 2011-09, Vol.39 (9), p.5621-5629

2011

Volltextzugriff (PDF)

International comparisons of domestic energy consumption

Energy economics, 2003-07, Vol.25 (4), p.359-373

2003

Volltextzugriff (PDF)

The impact of energy conservation on technology and economic growth

Resource and energy economics, 2003-02, Vol.25 (1), p.59-79

2003

Volltextzugriff (PDF)

Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)

European journal of cancer (1990), 2006-12, Vol.42 (18), p.3178-3185

2006

Volltextzugriff (PDF)

Diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer

Netherlands journal of medicine, 2006-09, Vol.64 (8), p.310-313

2006

Volltextzugriff (PDF)

Stability of patients' preferences for chemotherapy: the impact of experience

Medical decision making, 2001-07, Vol.21 (4), p.295-306

2001

Volltextzugriff (PDF)

APROSYS: Advances in secondary safety research

International journal of crashworthiness, 2008-12, Vol.13 (6), p.591-598

2008

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(174)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(120)
Life Sciences & Biomedicine
(115)
Humans
(91)
Female
(70)
Biological And Medical Sciences
(56)
Adult
(48)
Middle Aged
(48)
Oncology
(46)
Aged
(38)
Medical Sciences
(36)
Animals
(27)
Pharmacology. Drug Treatments
(26)
Chemotherapy
(25)
Male
(25)
Treatment Outcome
(23)
Breast Neoplasms - Drug Therapy
(22)
Fundamental And Applied Biological Sciences. Psychology
(20)
Tumors
(20)
Aged, 80 And Over
(18)
Antineoplastic Agents
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study

Molecular subtypes of breast cancer and amplification of topoisomerase IIα : predictive role in dose intensive adjuvant chemotherapy

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study

Response Shift in Quality of Life Measurement in Early-Stage Breast Cancer Patients Undergoing Radiotherapy

The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, ‘Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients’

Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer : is treatment worthwhile?

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

Survival of patients with ovarian cancer due to a mismatch repair defect

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study

Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas

Own power: Motives of having electricity without the energy company

International comparisons of domestic energy consumption

The impact of energy conservation on technology and economic growth

Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)

Diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer

Stability of patients' preferences for chemotherapy: the impact of experience

APROSYS: Advances in secondary safety research

Suchergebnisse filtern